세계의 장기칩 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)
Global Organ On A Chip Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
상품코드:1392303
리서치사:Value Market Research
발행일:2023년 11월
페이지 정보:영문 241 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
장기칩 시장의 세계 수요는 2022년 8,845만 달러에서 2030년 10억 4,983만 달러에 가까운 시장 규모에 도달할 것으로 추정되며, 2023-2030년 조사 기간 동안 36.24%의 CAGR을 기록할 것으로 예상됩니다.
장기칩은 인간 장기의 구조와 기능을 모방할 수 있는 미세유체 세포배양 장치입니다. 특정 장기의 생리적, 기계적 측면을 재현하여 기존 세포 배양 방식에 비해 더 정확하고 역동적인 인간 생물학 표현을 제공하는 것을 목표로 합니다. 각 장비는 특정 장기 및 조직의 미세 환경과 세포 간 상호 작용을 시뮬레이션하도록 설계되었습니다.
시장 역학:
장기칩 시장은 생의학 연구와 의약품 개발의 혁신 가능성으로 인해 빠르게 성장하고 있습니다. 이 기술은 장기와 조직을 보다 인간에 가까운 형태로 표현함으로써 기존 모델의 한계를 극복할 수 있습니다. 이 기술은 동물 실험에 대한 인도적인 대안을 제공하고, 윤리적 우려와 규제 압력이 높아짐에 따라 장기칩 플랫폼이 인간의 생물학을 정확하게 모방할 수 있다는 것은 약물 개발에 큰 의미가 있으며, 약물의 효능과 안전성에 대한 예측을 강화할 수 있습니다. 예측을 강화합니다. 또한, 이러한 모델은 치료에 대한 개인별 반응을 연구할 수 있게함으로써 개인 맞춤형 의료의 발전을 지원합니다. 이 시장은 정부, 연구 기관 및 제약 회사의 투자, 공동 연구 촉진 및 기술 발전에 의해 더욱 주도되고 있습니다. 미세 가공 기술의 지속적인 발전은 오가노이드 시스템의 확장성과 복잡성을 높이는 데 기여하고 있습니다. 만성 질환이 증가함에 따라 규제 당국의 장기칩 모델 검증은 의료 및 연구 방식에 혁명을 일으킬 수 있는 잠재력을 강조하고 있습니다. 파트너십이 활성화되고 수용이 확대됨에 따라, 장기칩 기술은 생의학 연구와 치료법 개발을 재구성하는 데 있어 매우 중요한 역할을 할 것입니다.
이 조사 보고서는 Porter's Five Forces 모델, 시장 매력도 분석 및 밸류체인 분석을 다룹니다. 이러한 도구는 산업 구조를 명확하게 파악하고 세계 수준에서 경쟁의 매력을 평가하는 데 도움이 될 수 있습니다. 또한 이러한 도구는 장기칩 세계 시장에서 각 부문을 포괄적으로 평가할 수 있으며, 장기칩 산업의 성장과 추세는 이 조사에 대한 전체적인 접근 방식을 제공합니다.
지역별 분석:
이 섹션에서는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카의 장기칩 시장의 현재와 미래 수요를 강조하는 지역 전망을 다룹니다. 또한, 모든 주요 지역의 개별 애플리케이션 부문의 수요, 추정 및 예측에 초점을 맞추고 있습니다.
맞춤형 요구사항이 있는 경우, 저희에게 연락하십시오. 우리의 조사팀은 고객의 요구에 따라 맞춤형 보고서를 제공 할 수 있습니다.
The global demand for Organ On A Chip Market is presumed to reach the market size of nearly USD 1049.83 MN by 2030 from USD 88.45 MN in 2022 with a CAGR of 36.24% under the study period 2023 - 2030.
An Organ-on-a-Chip (OOC) is a microfluidic cell culture device that is able to mimic the structure and function of human organs. It aims to replicate the physiological and mechanical aspects of specific organs to provide a more accurate and dynamic representation of human biology compared to traditional cell culture methods. Each device is designed to simulate the microenvironment and cellular interactions of a particular organ or tissue.
MARKET DYNAMICS:
The organ-on-a-chip market is expanding rapidly due to its transformative potential in biomedical research and drug development. This technology addresses the limitations of traditional models by providing more human-relevant representations of organs and tissues. It offers a humane alternative to animal testing, aligning with increasing ethical concerns and regulatory pressures. The ability of OOC platforms to mimic human biology accurately has profound implications for drug development, enhancing predictions of drug efficacy and safety. Moreover, these models support the advancement of personalized medicine by allowing the study of individual responses to treatments. The market is further driven by investments from governments, research institutions, and pharmaceutical companies, fostering collaborations and technological advancements. Ongoing improvements in microfabrication technology contribute to the scalability and complexity of OOC systems. With rising chronic diseases, the validation of OOC models by regulatory authorities underscores their potential to revolutionize healthcare and research practices. As partnerships flourish and acceptance grows, Organ-on-a-Chip technology is poised to play a pivotal role in reshaping biomedical research and therapeutic development.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organ on a chip. The growth and trends of organ on a chip industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the organ on a chip market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Organ On A Chip market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organ On A Chip market include Emulate, Inc., MIMETAS B.V., Valo Health, Nortis, Inc., AxoSim, BICO - THE BIO CONVERGENCE COMPANY, CN Bio Innovations Ltd, SynVivo, Inc., The Charles Stark Draper Laboratory, Inc., AlveoliX AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
3.7.1 Market Attractiveness Analysis By Product & Service
3.7.2 Market Attractiveness Analysis By Application
3.7.3 Market Attractiveness Analysis By End-use
3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY PRODUCT & SERVICE
5.1 Overview by Product & Service
5.2 Historical and Forecast Data
5.3 Analysis by Product & Service
5.4 Products Historic and Forecast Sales by Regions
5.5 Instruments Historic and Forecast Sales by Regions
5.6 Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Historic and Forecast Sales by Regions
5.7 Services Historic and Forecast Sales by Regions
6 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY APPLICATION
6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Drug Discovery Historic and Forecast Sales by Regions
6.5 Toxicology Research Historic and Forecast Sales by Regions
6.6 Others Historic and Forecast Sales by Regions
7 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY END-USE
7.1 Overview by End-use
7.2 Historical and Forecast Data
7.3 Analysis by End-use
7.4 Academic and Research Institutes Historic and Forecast Sales by Regions
7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions
8 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1. Overview, Historic and Forecast Data Sales Analysis
8.3.2. North America By Segment Sales Analysis
8.3.3. North America By Country Sales Analysis
8.3.4. United State Sales Analysis
8.3.5. Canada Sales Analysis
8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1. Overview, Historic and Forecast Data Sales Analysis
8.4.2. Europe by Segment Sales Analysis
8.4.3. Europe by Country Sales Analysis
8.4.4. United Kingdom Sales Analysis
8.4.5. France Sales Analysis
8.4.6. Germany Sales Analysis
8.4.7. Italy Sales Analysis
8.4.8. Russia Sales Analysis
8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1. Overview, Historic and Forecast Data Sales Analysis
8.5.2. Asia Pacific by Segment Sales Analysis
8.5.3. Asia Pacific by Country Sales Analysis
8.5.4. China Sales Analysis
8.5.5. India Sales Analysis
8.5.6. Japan Sales Analysis
8.5.7. South Korea Sales Analysis
8.5.8. Australia Sales Analysis
8.5.9. South East Asia Sales Analysis
8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1. Overview, Historic and Forecast Data Sales Analysis
8.6.2. Latin America by Segment Sales Analysis
8.6.3. Latin America by Country Sales Analysis
8.6.4. Brazil Sales Analysis
8.6.5. Argentina Sales Analysis
8.6.6. Peru Sales Analysis
8.6.7. Chile Sales Analysis
8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1. Overview, Historic and Forecast Data Sales Analysis
8.7.2. Middle East & Africa by Segment Sales Analysis
8.7.3. Middle East & Africa by Country Sales Analysis
8.7.4. Saudi Arabia Sales Analysis
8.7.5. UAE Sales Analysis
8.7.6. Israel Sales Analysis
8.7.7. South Africa Sales Analysis
8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE ORGAN ON A CHIP COMPANIES
9.1. Organ On A Chip Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10 . COMPANY PROFILES OF ORGAN ON A CHIP INDUSTRY
10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Emulate Inc.
10.3.1. Company Overview
10.3.2. Company Revenue
10.3.3. Products
10.3.4. Recent Developments
10.4. MIMETAS B.V.
10.4.1. Company Overview
10.4.2. Company Revenue
10.4.3. Products
10.4.4. Recent Developments
10.5. Valo Health
10.5.1. Company Overview
10.5.2. Company Revenue
10.5.3. Products
10.5.4. Recent Developments
10.6. Nortis Inc.
10.6.1. Company Overview
10.6.2. Company Revenue
10.6.3. Products
10.6.4. Recent Developments
10.7. AxoSim
10.7.1. Company Overview
10.7.2. Company Revenue
10.7.3. Products
10.7.4. Recent Developments
10.8. BICO - THE BIO CONVERGENCE COMPANY
10.8.1. Company Overview
10.8.2. Company Revenue
10.8.3. Products
10.8.4. Recent Developments
10.9. CN Bio Innovations Ltd
10.9.1. Company Overview
10.9.2. Company Revenue
10.9.3. Products
10.9.4. Recent Developments
10.10. SynVivo Inc.
10.10.1. Company Overview
10.10.2. Company Revenue
10.10.3. Products
10.10.4. Recent Developments
10.11. The Charles Stark Draper Laboratory Inc.
10.11.1. Company Overview
10.11.2. Company Revenue
10.11.3. Products
10.11.4. Recent Developments
10.12. AlveoliX AG
10.12.1. Company Overview
10.12.2. Company Revenue
10.12.3. Products
10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
